Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01234935
Recruitment Status : Completed
First Posted : November 4, 2010
Last Update Posted : January 9, 2018
Information provided by (Responsible Party):
Translational Oncology Research International

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 27, 2017
  Actual Study Completion Date : November 27, 2017